We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Auris Health, Inc. Stock

Invest in or calculate the value of your shares in Auris Health, Inc. or other pre-IPO companies through EquityZen's platform.

Get Started

Auris Health, Inc. Stock

Robotic endoscopy medical device company

About Auris Health, Inc. Stock

Founded

2007

Headquarters

San Carlos, CA, US

Total Funding

754M

Industries

Hardware, Software, Science and Engineering

Auris Health develops robotics technology for endoscopy - a nonsurgical medical procedure used to examine a person's digestive tract. The Company currently has one offering: Monarch Platform. The Monarch Platform and its accessories are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures. According to the company, its Monarch Platform improves upon existing minimally invasive techniques by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform to enable new categories of care. The Company states that lung cancer is the first disease it is targeting.

Auris had been in "stealth" for nearly a decade, but in March 2018, it attained FDA approval for its Monarch Platform to be used for "bronchoscopic procedures," such as diagnosing lung cancer.

The Company was incorporated in 2007 and is based in the San Francisco Bay area.

Bronchoscopy Overview:

Source: Crunchbase; Auris

Investors in Auris Health, Inc.

Discover investors in Auris Health, Inc. stock and explore their portfolio companies

Auris Health, Inc. Management

Leadership team at Auris Health, Inc.

Co-Founder & CEO

Fred Moll

Chief Strategy Officer

Josh DeFonzo

Locked Features

Join now and verify your accreditation status to gain access to:

  • Auris Health, Inc. current valuation
  • Auris Health, Inc. stock price
  • Available deals in Auris Health, Inc. and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Auris Health, Inc. stock?

Accredited investors can buy pre-IPO stock in companies like Auris Health, Inc. through EquityZen funds. These investments are made available by existing Auris Health, Inc. shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Auris Health, Inc. stock?

Shareholders can sell their Auris Health, Inc. stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."